Skip to main content
Marilyn Tan

Marilyn Tan

Marilyn Tan, MD, FACE, FACP — Clinical Professor of Medicine (Endocrinology) at Stanford University School of Medicine and Chief of the Endocrine Clinic at Stanford Health Care.

Oct 22, 2026

14:46
I know we can talk about your trial that you guys did and you have a better solution, but like, is there anything that you could eat that would make that happen?
14:53
Yeah.
14:54
So in terms of the safety part, I mean, having a little bit of dextrose to bring up your glucose or a little bit of glucose to bring it up, like the juice or something is important to save you from that very dangerous low and then people need a kind of stabilizer.
15:07
And so it really depends on the individual person.
15:10
Commonly, patients will tell me a piece of cheese actually helps to hold them over.
15:15
And so usually you need something with fat and protein and a little bit of slowly absorbed carbohydrates.
15:20
Really, the goal of management of the post-bariatric hypoglycemia is to prevent it and avoid it.

8 MINS LATER

23:09
one of my colleagues actually
20:21
So prior to the GLP-1 drugs, can you just talk to us a little bit about what was the landscape like, like, when you tried to have-- when you had patients who wanted to lose weight and you were trying to help them, what did that look like and how well did it work?
20:35
So I remember in medical school, one of my attendings said, "It's just very simple.
20:40
It's calories in, calories out," right? That's 3,000 calories or so, you know, is one pound.
20:47
Um, that's what happens when you're in a lab.
20:49
But we all know that the reality of real life is that there are people who can eat whatever they want and never gain weight, and those who truly restrict themselves and cannot lose weight.
20:59
So while the science says it's calories in, calories out, there is certainly more to it than that.
21:04
There's basal metabolic rate and various other things.

15 MINS LATER

36:21
So talk a little bit about where besides weight and diabetes have we seen effects with GLP-1 drugs, and sort of how convinced are you that they are beneficial in some of these other settings?

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.